Moravek Biochemicals (United States)

Spirodiketopiperazine-Based CCR5 Inhibitor Which Preserves CC-Chemokine/CCR5 Interactions and Exerts Potent Activity against R5 Human Immunodeficiency Virus Type 1 In Vitro

Kenji Maeda, Hirotomo Nakata, Yasuhiro Koh et al. · Journal of Virology · 2004 · 221 citations · Full text

Medicine, Human Retrovirus, Immunology +13

Cellular pharmacology and biological activity of 5-carboranyl-2′-deoxyuridine

Raymond F. Schinazi, Naganna M. Goudgaon, Géraldine Fulcrand et al. · International Journal of Radiation Oncology*Biology*Physics · 1994 · 47 citations

Molecular Pharmacology, Biochemistry, Medicine +5

Cellular Pharmacology of the<scp>D</scp>- and<scp>L</scp>-Enantiomers of β-5-<i>o</i>-Carboranyl-2′-deoxyuridine

Selwyn J. Hurwitz, Li Ma, Alessandra Eleuteri et al. · Nucleosides Nucleotides & Nucleic Acids · 2000 · 16 citations

Benzoxaborole antimalarial agents. Part 3: design and syntheses of (carboxy‐¹³C‐3,3‐²H₂)‐labeled and (3‐¹⁴C)‐labeled 7‐(2‐carboxyethyl)‐1,3‐dihydro‐1‐hydroxy‐2,1‐benzoxaboroles

Yong‐Kang Zhang, Jacob J. Plattner, Eric E. Easom et al. · Journal of Labelled Compounds and Radiopharmaceuticals · 2012 · 15 citations

Carboxy‐ 13, Medicinal Chemistry, Diversity Oriented Synthesis +14

Synthesis of labeled ambroxol and its major metabolites

Bachir Latli, Matt Hrapchak, Heinz‐Karl Switek et al. · Journal of Labelled Compounds and Radiopharmaceuticals · 2009 · 12 citations

Medicinal Chemistry, Deuterium‐labeled Ambroxol, Pharmaceutical Science +13